Cumberland Pharmaceuticals Ratios (2010-2026) | CPIX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)	80.78%	83.55%	60.26%	80.21%	55.76%	63.99%	-11.72%	53.63%	57.09%	82.49%	83.64%	51.11%	82.63%	85.44%	159.55%	63.87%	81.44%	46.53%	145.49%	78.82%
EBT Margin (Quarter)	8.09%	-19.52%	-52.59%	-12.49%	-13.18%	-3.65%	-26.43%	1.94%	7.98%	-10.47%	-67.11%	-22.25%	-11.08%	-16.79%	-18.77%	10.70%	-6.73%	-23.44%	-10.18%	-34.36%
EBIT Margin (Quarter)	-15.85%	-19.37%	-52.33%	-11.56%	-17.93%	-2.53%	-24.97%	-16.60%	0.21%	-18.51%	-66.07%	-22.00%	-10.42%	-18.65%	-17.65%	11.03%	-6.90%	-23.70%	-10.02%	-34.27%
EBITDA Margin (Quarter)	-15.85%	-19.37%	-52.33%	-11.56%	-17.93%	-2.53%	-24.97%	-16.60%	0.21%	-18.51%	-66.07%	-22.00%	-10.42%	-18.65%	-17.65%	11.03%	-6.90%	-23.70%	-10.02%	-34.27%
Operating Margin (Quarter)	-15.85%	-19.37%	-52.33%	-11.56%	-17.93%	-2.53%	-24.97%	-16.60%	0.21%	-18.51%	-66.07%	-22.00%	-10.42%	-18.65%	-17.65%	11.03%	-6.90%	-23.70%	-10.02%	-34.27%
Net Margin (Quarter)	7.10%	6.15%	6.05%					1.87%	7.92%	-10.54%	-67.38%	-22.39%	-11.20%	-16.92%	-15.28%	10.66%	-6.78%	-23.50%	-7.89%	-30.75%
FCF Margin (Quarter)	24.13%	10.31%	23.45%	-1.59%	21.30%	22.29%	41.56%	-16.54%	47.42%	11.73%	10.60%	-25.63%	-8.76%	5.06%	18.23%	32.88%	7.54%	1.97%	0.02%	4.24%
Efficiency
Inventory Average (Quarter)	10.06M	10.18M	9.35M	9.15M	9.65M	10.03M	10.26M	10.02M	10.55M	9.80M	6.64M	4.47M	4.31M	4.41M	4.25M	4.05M	3.66M	3.08M	4.58M	5.84M
Assets Average (Quarter)	91.10M	88.21M	86.02M	90.58M	94.61M	91.65M	91.85M	91.20M	89.42M	88.56M	84.76M	81.64M	80.01M	77.63M	76.17M	72.76M	68.92M	66.90M	71.36M	73.91M
Equity Average (Quarter)	47.34M	47.23M	44.62M	41.70M	40.00M	39.05M	37.43M	36.01M	36.44M	36.25M	32.46M	28.22M	26.61M	25.25M	23.51M	25.44M	28.01M	26.74M	25.34M	23.09M
Invested Capital (Quarter)	47.81M	46.65M	42.60M	40.79M	39.20M	38.89M	35.97M	36.05M	36.84M	35.66M	29.26M	27.19M	26.03M	30.46M	27.65M	28.34M	27.68M	25.80M	24.88M	21.30M
Asset Utilization Ratio (Quarter)	0.43	0.43	0.42	0.40	0.40	0.45	0.46	0.44	0.45	0.44	0.47	0.48	0.47	0.47	0.50	0.56	0.61	0.62	0.62	0.57
Leverage & Solvency
Interest Coverage Ratio (Quarter)	-55.52	-78.09	-156.99	-10.80	-13.42	-1.93	-12.69	-8.22	0.12	-16.96	-34.56	-15.77	-8.13	-12.33	-8.25	7.89	-6.82	-17.92	-12.14	-36.46
Debt to Equity (Quarter)	0.29	0.32	0.35	0.49	0.48	0.46	0.45	0.45	0.36	0.36	0.44	0.59	0.62	0.66	0.68	0.18	0.19	0.20	0.21	0.25
Debt Ratio (Quarter)	0.16	0.17	0.18	0.21	0.21	0.19	0.17	0.18	0.15	0.15	0.16	0.20	0.20	0.21	0.20	0.07	0.08	0.08	0.07	0.07
Equity Ratio (Quarter)	0.54	0.53	0.50	0.42	0.42	0.43	0.39	0.40	0.41	0.41	0.36	0.33	0.33	0.32	0.30	0.41	0.41	0.39	0.32	0.30
Times Interest Earned (Quarter)	-55.52	-78.09	-156.99	-10.80	-13.42	-1.93	-12.69	-8.22	0.12	-16.96	-34.56	-15.77	-8.13	-12.33	-8.25	7.89	-6.82	-17.92	-12.14	-36.46
Valuation
Enterprise Value (Quarter)	-25.81M	-26.02M	-27.25M	-17.50M	-18.48M	-19.81M	-20.05M	-16.70M	-18.57M	-18.84M	-18.67M	-18.85M	-17.65M	-17.77M	-18.27M	-15.42M	-16.40M	-15.52M	-11.78M	-11.34M
Return Ratios
Return on Sales (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%		0.00%	0.00%	0.00%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	-6.51%	-7.21%	-11.50%	-13.09%	-12.87%	-11.73%	-9.02%	-9.08%	-6.52%	-9.23%	-16.83%	-17.92%	-19.80%	-23.14%	-14.44%	-6.92%	-6.66%	-7.66%	-8.07%	-18.30%
Return on Invested Capital (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%		0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%		0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Cumberland Pharmaceuticals Ratios (2010-2026) | CPIX

Create an account

Sign In

Reset Password